Rong Xu

Sources

Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.

1. [1]

   COVID-19 associated with increase in new diagnoses of type 1 diabetes in youth, by as much as 72% | School of Medicine | School of Medicine | Case Western Reserve University

   4 source claims · Reviewed Sep 9, 2026

   Show supporting evidence

   Identity: Rong Xu

   Rong Xu, also a corresponding author, professor of biomedical informatics at the School of Medicine and director of the Center for Artificial Intelligence in Drug Discovery, said further research is needed to examine if the increased risk of new onset T1D following SARS-CoV2 infection in pediatric patients will persist, who are vulnerable, and how to treat COVID-19 associated T1D in children.

   Professional role: also a corresponding author, professor of biomedical informatics at the School of Medicine and director of the Center for Artificial Intelligence in Drug Discovery

   also a corresponding author, professor of biomedical informatics at the School of Medicine and director of the Center for Artificial Intelligence in Drug Discovery

   Professional role: director of the Center for Artificial Intelligence in Drug Discovery

   Rong Xu, also a corresponding author, professor of biomedical informatics at the School of Medicine and director of the Center for Artificial Intelligence in Drug Discovery, said further research is needed to examine if the increased risk of new onset T1D following SARS-CoV2 infection in pediatric patients will persist, who are vulnerable, and how to treat COVID-19 associated T1D in children.

   Professional role: professor of biomedical informatics

   Rong Xu, also a corresponding author, professor of biomedical informatics at the School of Medicine and director of the Center for Artificial Intelligence in Drug Discovery, said further research is needed to examine if the increased risk of new onset T1D following SARS-CoV2 infection in pediatric patients will persist, who are vulnerable, and how to treat COVID-19 associated T1D in children.